MTS Max Marchione on Building SuperPower, Compounding Economics, and Clinical Authority | MTS Live
May 12, 2026
Max Marchione, founder in peptide-focused healthcare and entrepreneurship, explains how peptides act as therapeutic bioregulators and why they matter. He discusses microdosing GLP-1, sleep-enhancing peptides like epitalon, launching SuperPower Peptides, community-building tactics, clinical education for doctors, and the economics and market structure of compounding and peptide brands.
AI Snips
Chapters
Transcript
Episode notes
Peptides Defined As Small Functional Proteins
- Peptides are short chains of amino acids that function as small proteins regulating biology.
- Max explains peptides as sub-40 amino-acid chains (e.g., creatine, collagen, insulin) that can be injected for targeted effects.
Doctor Consensus Prompted Personal Trial
- Max's clinician network convinced him to try peptides after he showed his supplement stack.
- Nearly all top doctors he consulted had recommended peptides and many had used them for decades, which prompted him to experiment personally.
Microdose GLP‑1 And Reserve Peptides As Needed
- Use a tailored mix: Max microdoses a GLP‑1 biweekly and uses other peptides only as needed.
- He microdoses GLP‑1 for appetite, thymosin alpha‑1 for immunity, and BPC‑157/TB‑500 for injury recovery.